Deborah Kochevar T.'s most recent trade in Elanco Animal Health Inc was a trade of 18,169 Common Stock done . Disclosure was reported to the exchange on Nov. 29, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Elanco Animal Health Inc | Deborah T. Kochevar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Nov 2024 | 18,169 | 79,400 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories | Deborah T. Kochevar | Director | 13 May 2024 | 1,311 | 1,311 | - | - | Stock Options (Right to Buy) | ||
| Charles River Laboratories | Deborah T. Kochevar | Director | 13 May 2024 | 559 | 7,894 (0%) | 0% | 228.4 | 127,681 | Common Stock | |
| Elanco Animal Health Inc | Deborah Kochevar T. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2023 | 20,374 | 61,231 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories | Deborah T. Kochevar | Director | 15 May 2023 | 1,669 | 1,669 | - | - | Stock Options (Right to Buy) | ||
| Charles River Laboratories | Deborah T. Kochevar | Director | 15 May 2023 | 664 | 7,335 (0%) | 0% | 0 | Common Stock | ||
| Elanco Animal Health Inc | Deborah T. Kochevar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 18,649 | 40,857 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories | Deborah T. Kochevar | Director | 11 May 2022 | 1,582 | 1,582 | - | - | Stock Options (Right to Buy) | ||
| Charles River Laboratories | Deborah T. Kochevar | Director | 11 May 2022 | 575 | 6,671 (0%) | 0% | 0 | Common Stock | ||
| Elanco Animal Health Inc | Deborah T. Kochevar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 7,307 | 22,208 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories | Deborah T. Kochevar | Director | 06 Aug 2021 | 2,620 | 6,101 (0%) | 0% | 406.7 | 1,065,473 | Common Stock | |
| Charles River Laboratories | Deborah T. Kochevar | Director | 06 Aug 2021 | 2,539 | 9,622 (0%) | 0% | 164.2 | 417,005 | Common Stock | |
| Charles River Laboratories | Deborah T. Kochevar | Director | 06 Aug 2021 | 2,539 | 0 | - | - | Stock Options (Right to Buy) | ||
| Charles River Laboratories | Deborah T. Kochevar | Director | 06 Aug 2021 | 901 | 8,721 (0%) | 0% | 405.7 | 365,562 | Common Stock | |
| Charles River Laboratories | Deborah T. Kochevar | Director | 06 Aug 2021 | 5 | 6,096 (0%) | 0% | 407.2 | 2,036 | Common Stock | |
| Charles River Laboratories | Deborah T. Kochevar | Director | 07 May 2021 | 1,151 | 1,151 | - | - | Stock Options (Right to Buy) | ||
| Charles River Laboratories | Deborah T. Kochevar | Director | 07 May 2021 | 355 | 7,083 (0%) | 0% | 0 | Common Stock | ||
| Elanco Animal Health Inc | Deborah T. Kochevar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2020 | 5,885 | 14,901 (0%) | 0% | 0 | Common Stock |